Celecoxib alleviates AKT/c-Met-triggered rapid hepatocarcinogenesis by suppressing a novel COX-2/AKT/FASN cascade
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Celecoxib alleviates AKT/c-Met-triggered rapid hepatocarcinogenesis by suppressing a novel COX-2/AKT/FASN cascade
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-09-05
DOI
10.1002/mc.22904
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice
- (2017) Shanshan Zhang et al. JOURNAL OF HEPATOLOGY
- Methylated urolithin A, the modified ellagitannin-derived metabolite, suppresses cell viability of DU145 human prostate cancer cells via targeting miR-21
- (2016) Benhong Zhou et al. FOOD AND CHEMICAL TOXICOLOGY
- Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice
- (2016) Junjie Hu et al. Scientific Reports
- Lipogenesis in cancer progression (Review)
- (2014) CATHERINE MOUNIER et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends
- (2013) Matthias S. Matter et al. JOURNAL OF HEPATOLOGY
- Celecoxib Inhibits Interleukin-6/Interleukin-6 Receptor-Induced JAK2/STAT3 Phosphorylation in Human Hepatocellular Carcinoma Cells
- (2011) Y. Liu et al. Cancer Prevention Research
- Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways
- (2011) Olorunseun O. Ogunwobi et al. CLINICAL & EXPERIMENTAL METASTASIS
- Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma
- (2011) Qian Zhou et al. Future Oncology
- c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma
- (2011) Hanning You et al. HEPATOLOGY
- Novel combination of Celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells
- (2010) Antonella Cusimano et al. CELL CYCLE
- Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma
- (2010) Diego F. Calvisi et al. GASTROENTEROLOGY
- Hepatocellular carcinoma: a global view
- (2010) Ju Dong Yang et al. Nature Reviews Gastroenterology & Hepatology
- The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective
- (2010) A. P. Venook et al. ONCOLOGIST
- HGF/Met signalling promotes PGE2 biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells
- (2009) A. E. Moore et al. CARCINOGENESIS
- The role of COX-2 in intestinal inflammation and colorectal cancer
- (2009) D Wang et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now